Leiv Lea, Chief Financial Officer at Corvus Pharmaceuticals, Inc. (CRVS), bought 49,400 shares at $4.15 ($205K) on 2018-12-21, disclosed to the SEC on 2018-12-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.15 | 24,700 | $103K | 50.0% |
| 2 | $4.15 | 24,700 | $103K | 50.0% |
| Total | $4.15 avg | 49,400 | $205K | 100% |
| Filing → |
| CRVS | BUY | 2019-06-10 | $89K | — | Filing → |
| PCYC | BUY | 2007-08-22 | $4K | — | Filing → |
| PCYC | BUY | 2007-08-22 | $6K | — | Filing → |